These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19281727)

  • 1. Daptomycin elimination by CVVH in vitro: evaluation of factors influencing sieving and membrane adsorption.
    Wagner CC; Steiner I; Zeitlinger M
    Int J Clin Pharmacol Ther; 2009 Mar; 47(3):178-86. PubMed ID: 19281727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics Removal by Continuous Venovenous Hemofiltration with a Novel Asymmetric Triacetate Membrane Hemofilter: An in vitro Study.
    Körtge A; Majcher-Peszynska J; Heskamp B; Wasserkort R; Mitzner S
    Blood Purif; 2021; 50(6):899-905. PubMed ID: 33631754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS; Matzke GR; Frye RF; Palevsky PM
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing.
    Bouman CS; van Kan HJ; Koopmans RP; Korevaar JC; Schultz MJ; Vroom MB
    Intensive Care Med; 2006 Dec; 32(12):2013-9. PubMed ID: 17043848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration.
    Wenisch JM; Meyer B; Fuhrmann V; Saria K; Zuba C; Dittrich P; Thalhammer F
    J Antimicrob Chemother; 2012 Apr; 67(4):977-83. PubMed ID: 22210754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo Rezafungin Adsorption and Clearance During Continuous Renal Replacement Therapy.
    Jang SM; Hough G; Mueller BA
    Blood Purif; 2018; 46(3):214-219. PubMed ID: 30048960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept clearance during an in vitro model of continuous venovenous hemofiltration.
    Fleming GM; Salama NN; Eid SK; Cooke KR; Mueller BA
    Blood Purif; 2009; 28(4):348-53. PubMed ID: 19729904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis.
    Matzke GR; Frye RF; Joy MS; Palevsky PM
    Pharmacotherapy; 2000 Jun; 20(6):635-43. PubMed ID: 10853618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
    Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
    Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin clearance during modeled continuous renal replacement therapy.
    Churchwell MD; Pasko DA; Mueller BA
    Blood Purif; 2006; 24(5-6):548-54. PubMed ID: 17124423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C; Chauveau P; Guisset O; Cazin MC; Lasseur C; Gabinsky C; Winnock S; Montaudon D; Bedry R; Nouts C; Pillet O; Benissan GG; Favarel-Guarrigues JC; Castaing Y
    Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone pharmacokinetic properties during continuous veno-veno haemofiltration using an in vitro adult, paediatric and neonatal model.
    Harvey B; Johnson TN; Yeomanson D; Mulla H; Mayer AP
    Perfusion; 2014 Jan; 29(1):32-8. PubMed ID: 23863489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
    Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
    Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
    Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drastic reduction of piperacillin-tazobactam concentrations in an in-vitro model of continuous venovenous hemofiltration: proposal of an innovative modality of administration to maintain them at constant concentration.
    Ferrannini M; Niscola P; Falcone C; Noce A; Pastore A; Di Giovamberardino G; Tendas A; Scaramucci L; Di Daniele N; Palumbo R
    Cardiovasc Hematol Agents Med Chem; 2013 Sep; 11(3):187-93. PubMed ID: 23547902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo Elimination of Clonidine by Continuous Venovenous Hemofiltration in Critically Ill Patients.
    van den Oever HLA; Zeeman M; Nassikovker P; Bles C; van Steveninck FAL; de Meijer AR; Kruisdijk-Gerritsen A; Arbouw M
    Blood Purif; 2020; 49(5):622-626. PubMed ID: 31962323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different doses in continuous veno-venous hemofiltration on plasma lactate in critically ill patients.
    Liu Y; Ouyang B; Chen J; Chen M; Ma J; Wu J; Huang S; Li L; Liu Z; Guan X
    Chin Med J (Engl); 2014; 127(10):1827-32. PubMed ID: 24824239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Corral E; Martín A; Solinís MA; Muñoz JL
    Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: evaluation of the sieving coefficient.
    Arzuaga A; Isla A; Gascón AR; Maynar J; Corral E; Pedraz JL
    Blood Purif; 2006; 24(4):347-54. PubMed ID: 16645266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.